Literature DB >> 3434107

Severe hypophosphatemia following elective abdominal aortic bypass grafting.

P T Andersen1, L K Nielsen, J Møller-Petersen, E W Henneberg, K Egeblad.   

Abstract

Serum phosphate levels and urinary phosphate excretion were investigated in ten patients undergoing elective abdominal aortic bypass grafting. The abdominal aorta was cross-clamped peroperatively for 50-95 min. The median serum phosphate was within reference range (0.80-1.55 mmol/l) during cross-clamping and for the first 24 hours after revascularization of the lower limbs. At 48 hours there was statistically significant fall in the serum phosphate level in all patients, with median reaching a nadir of 0.49 mmol/l. At 72 hours this level had risen to 0.69 mmol/l, and reference range had been regained 7 days postoperatively. The median urinary phosphate excretion (mmol) was 38.4 during the first 24 postoperative hours, and 34.7 and 10.0 on the 2 subsequent days. The median ratio of urinary phosphate to creatinine clearance was, respectively, 0.47, 0.37, 0.09 and 0.08 on postoperative days 1, 2, 3 and 7. The study indicated that patients undergoing aortic bypass grafting with protracted regional muscular ischemia may constitute a risk group with respect to development of severe postoperative hypophosphatemia.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3434107

Source DB:  PubMed          Journal:  Acta Chir Scand        ISSN: 0001-5482


  4 in total

1.  Hypophosphatemia and recovery of post-hepatectomy liver insufficiency.

Authors:  Julie Hallet; Paul J Karanicolas; Francis S W Zih; Eva Cheng; Julia Wong; Sherif Hanna; Natalie G Coburn; Calvin H L Law
Journal:  Hepatobiliary Surg Nutr       Date:  2016-06       Impact factor: 7.293

2.  Hepatic resection-related hypophosphatemia is of renal origin as manifested by isolated hyperphosphaturia.

Authors:  Ronald R Salem; Kory Tray
Journal:  Ann Surg       Date:  2005-02       Impact factor: 12.969

3.  High incidence of hypophosphatemia in surgical intensive care patients: efficacy of phosphorus therapy on myocardial function.

Authors:  J F Zazzo; G Troché; P Ruel; J Maintenant
Journal:  Intensive Care Med       Date:  1995-10       Impact factor: 17.440

4.  Clinically-defined preoperative serum phosphorus abnormalities and outcomes of coronary artery bypass grafting: Retrospective analysis using inverse probability weighting adjustment.

Authors:  Jungchan Park; Kwan Young Hong; Jeong Jin Min; Eunjin Kwon; Young Tak Lee; Wook Sung Kim; Hye Seung Kim; Kyunga Kim; Jong-Hwan Lee
Journal:  PLoS One       Date:  2019-12-18       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.